mRNA-1647 & mRNA-1230

About Moderna

Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. Its historic achievement was the rapid development and global commercialization of SPIKEVAX®, a COVID-19 vaccine that proved the platform's efficacy and scalability. The company's strategy leverages its validated mRNA platform, substantial financial resources, and commercial infrastructure to build a durable portfolio of vaccines and therapeutics, aiming to address a wide spectrum of diseases with high unmet need.

Therapeutic Areas

Other Cytomegalovirus (CMV) prevention Drugs